Medscape |
---|
Results From Halted Islatravir Antiretroviral Trial |
![]() Concerns about lower lymphocyte levels in HIV with the once-daily oral drug islatravir in combination with doravirine changed the trajectory of clinical trial plans that are now back on track, according to investigators. |
||
2023-08-04 Read more about this article in source |
-
The ‘Six Pillars of Brain Health’ offers a game plan to maintain cognitive function 04/25/2025
-
Avocados, cheese and nuts are high in calories but have big health benefits 04/25/2025
-
Perfecting the squat before trying a lunge can start you off on the right foot 04/25/2025